摩根大通：中国医疗器械_欧盟采购禁令带来负面影响；中国政府创新推动产生积极作用

Asia Pacific Equity Research 23 June 2025 J P M O R G A N This material is neither intended to be distributed to Mainland China investors nor to provide securities investment consultancy services within the territory of Mainland China. This material or any portion hereof may not be reprinted, sold or redistributed without the written consent of J.P. Morgan. China Medtech An eventful Friday: EU procurement ban negative; China government innovation push positive On June 20th, we noted two policy items in the ...